As the lifespan of laboratory mice goes, Dr Vincent Tuohy‘s have won the lottery. But only those who were injected with his groundbreaking breast cancer vaccine. none of these tiny research creatures, bred to make them prone to the disease, went on to develop it. all of the others did.
Despite the seriousness of the disease, many victims do not show any lung cancer symptoms until the cancer has grown or spread to other parts of the body. The most apparent lung cancer symptoms do not usually appear until the illness reaches the more advanced stages, and even then there are few lung cancer symptoms that are specific to lung cancer only.
I wonder why diaphoresis can be the symptom of lung cancer.
Lung cancer patient makes too much sweat??
If so, could you clarify the reason to me?
PRINCETON, N.J., May 21, 2010 (BUSINESS WIRE) —-Results to be Presented at 46th Annual Meeting of the American Society of Clinical Oncology
Lung cancer is very perilous and prognosis for the disease is very poor. Thus no one can afford to wait to develop the disease and then treat it. According to data from the U.S. government, more than 200,000 people in the U.S. are diagnosed and more than 160,000 die from the disease each year.
LOS ANGELES, May 06, 2010 (BUSINESS WIRE) —-Company Reports first Quarter 2010 Net Loss for Common Shareholders of $3 Million, or $0.07 per Share, with Adjusted Net Income of $9 Million, or $0.22 per Share
Of all the types of cancer that we have become familiar with in the past few decades, lung cancer is at or near the top of the list. Breast cancer gets as much attention from media, from patients and family members as lung cancer, but lung cancer is also quite feared among the general population.
Phase 2 study of bafetinib for advanced prostate cancer April 07, 2010
CytRx Corporation announced plans to initiate a Phase 2 trial in the second half of 2010 to evaluate the effectiveness and safety of its drug candidate bafetinib (formerly known as INNO-406) in patients with an advanced form of prostate cancer known as metastatic hormone-refractory prostate cancer.
